Webinar 2 Deconstructing the Vicious Cycle of Cardiorenal Anemia Syndrome and Improving Care The Emerging Promise of Next-Gen IV
IV Iron in CRAS - Core Clinical Concepts
•
31m
Cardiorenal Anemia syndrome presents a complex challenge, particularly in managing iron deficiency. Effective iron supplementation is crucial, with hepcidin playing a key role in iron homeostasis. Clinical trials show that next-generation IV iron products outperform oral iron in treating heart failure patients. Updated guidelines now recommend IV iron to improve patient quality of life, and ongoing research continues to explore its benefits in heart failure and chronic kidney disease.
Up Next in IV Iron in CRAS - Core Clinical Concepts
-
Webinar 3 An Infusion of Change in th...
The final session on cardiorenal anemia syndrome focuses on treatment strategies to improve patient outcomes. It covers intravenous iron formulations, their dosing, and indications, while emphasizing the importance of recognizing adverse drug reactions. A patient case study highlights the managem...
-
Understanding Cardiorenal Syndrome an...
A Dr Brendan nephrologist, discusses key concepts of Cardiorenal syndrome and iron deficiency. He explains how chronic inflammation in patients with heart failure and chronic kidney disease affects iron absorption, making intravenous iron crucial. Recent trials show that intravenous iron reduces ...
